Prosight Management, LP - CIDARA THERAPEUTICS INC ownership

CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 47 filers reported holding CIDARA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Prosight Management, LP ownership history of CIDARA THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$603,000
+3.3%
358,963
+63.0%
0.30%
+18.8%
Q1 2019$584,000
+1.0%
220,264
-10.4%
0.26%
-14.1%
Q4 2018$578,000
-59.6%
245,764
-24.4%
0.30%
-62.6%
Q3 2018$1,430,000
-76.3%
324,902
-72.0%
0.80%
-82.0%
Q2 2018$6,025,000
+26.9%
1,158,700
-2.3%
4.42%
+48.4%
Q1 2018$4,746,000
-57.6%
1,186,355
-28.0%
2.98%
-63.9%
Q4 2017$11,206,0001,647,8798.24%
Other shareholders
CIDARA THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 1,677,194$819,0001.02%
BVF INC/IL 6,861,127$3,352,0000.16%
5AM Venture Management, LLC 1,134,511$554,0000.14%
Knott David M Jr 635,254$310,0000.13%
Nantahala Capital Management 4,819,090$2,355,0000.12%
West Family Investments, Inc. 368,910$180,0000.07%
Stonepine Capital Management, LLC 208,443$102,0000.05%
JEPPSON WEALTH MANAGEMENT, LLC 181,075$88,0000.04%
Ground Swell Capital, LLC 11,397$6,0000.01%
Point72 Asset Management, L.P. 4,200,000$2,052,0000.01%
View complete list of CIDARA THERAPEUTICS INC shareholders